New treatments targeting lipoprotein(a) could significantly change cardiovascular risk assessment and management. Lipoprotein(a) is a cholesterol that raises the risk of heart attacks and strokes.
Lipoprotein(a) levels are largely determined by genetics, with 70-90% of variation inherited. Higher Lp(a) levels correlate with an increased risk of heart attacks, strokes, and aortic valve disease. Most commonly used cholesterol-lowering medications, including statins, do not reduce Lp(a). However, newer drugs like PCSK9 inhibitors can lower Lp(a) by 15-30%.
Mindfulness training also plays a role in heart health. Research shows that daily mindfulness practice can lead to measurable improvements in cardiovascular health within just eight weeks. The therapeutic dose linked with blood pressure improvements involves daily practice reinforced by weekly sessions.
Regular consumption of pistachios has shown benefits as well. Studies indicate that eating pistachios can lead to lower LDL cholesterol and blood pressure. A handful provides 174 calories and 6.1 grams of protein.
The evolving understanding of lipoprotein(a) is crucial for future cardiovascular strategies. Currently, Lp(a) isn’t included in routine cholesterol tests, and there’s little we can do about it.
The impact of mindfulness on heart health is promising. Rosalba Hernandez stated, “The therapeutic dose that was most consistently linked with improvements in blood pressure, inflammation and endothelial function was daily practice reinforced by weekly sessions over eight to 12-week periods.” Mindfulness helps regulate the body effectively.
The integration of new treatments for lipoprotein(a) alongside lifestyle changes like mindfulness and diet could redefine cardiovascular disease management. Multiple clinical trials have found that regularly eating pistachios can lead to lower total cholesterol and LDL ‘bad’ cholesterol.
